Q: Could you comment on VHI's Q1 earnings? At first glance, they seemed to be pretty solid, however, after initially rising, the SP fell nearly 7% on Friday. Seems like an overreaction (which is common in these markets) but as always, would appreciate your analysis.
5i Research Answer:
VHI did hit a new high before reversing. EPS of 2c missed estimates of 4.3c; Revenue of $21.7M beat estimates of $21.3M. EBITDA of $5.6M beat estimates by 3.5%. Organic growth was 3%, ARR increased 4%, EBITDA margin was 26% and cash is $90M. With acquisitions, total revenue rose 42%. General and admin costs did increase. Based on consensus, very solid EPS growth is expected this year (40%) and next (35%+). The stock is still up 69% in 52 weeks and we would not take the stock drop as a reflection of outlook, though it did technically 'miss' EPS estimates.